ForwardVue Pharma is an emerging biopharmaceutical company developing a small synthetic compound caroboxyamidotriazole, that acts via the novel mechanism of ORAI-1 inhibition and can be formulated to deliver potent anti-angiogenic effects for 6-12 months. Carboxyamidotriazole has been administered to over 900 patients systemically to treat advanced cancer thereby allowing more rapid progress to Phase 2 once IND enabling ocular toxicity is completed. ForwardVue Pharma has secured initial seed round funding in order to advance pre-clinical development of potent long acting anti-angiogenic molecules directed against diabetic eye disease and neovascular age related macular degeneration.
View Top Employees from ForwardVue PharmaWebsite | http://www.forwardvuepharma.com |
Employees | 3 (2 on RocketReach) |
Founded | 2020 |
Technologies |
JavaScript,
HTML,
Twitter
+5 more
(view full list)
|
Industry | Biotechnology, Drug Delivery, Pharmaceuticals |
Looking for a particular ForwardVue Pharma employee's phone or email?
Alan Franklin is the Founder of ForwardVue Pharma.
2 people are employed at ForwardVue Pharma.